742503
硅酸钙
purum, 12-22% Ca (as CaO) basis, ≥87% SiO2 basis
别名:
Calsilite, 单硅酸钙, 含水硅酸钙, 硅酸、钙盐, 聚硅酸钙
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
化学文摘社编号:
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352301
EC Number:
215-710-8
MDL number:
Assay:
≥87% SiO2 basis
Form:
solid
Quality Level
grade
purum
assay
≥87% SiO2 basis
form
solid
composition
Ca (as CaO), 12-22% T
loss
≤7.0% loss on drying, 2h; 105°C
particle size
7.0-10.0 μm
pH
9.5-11.5 (5% in H2O)
density
2.9 g/mL at 25 °C (lit.)
SMILES string
[Ca++].[O-][Si]([O-])=O
InChI
1S/Ca.O3Si/c;1-4(2)3/q+2;-2
InChI key
OYACROKNLOSFPA-UHFFFAOYSA-N
Application
硅酸钙可以用作合成几种生物材料的前体。此类应用的实例包括用于骨组织再生的生物相容性纳米复合材料的制备和溶胶-凝胶杂化生物活性玻璃的合成。
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Rania Hassan Fahmy
AAPS PharmSciTech, 13(3), 990-1004 (2012-07-19)
Multiparticulate floating drug delivery systems have proven potential as controlled-release gastroretentive drug delivery systems that avoid the "all or none" gastric emptying nature of single-unit floating dosage forms. An objective of the presence investigation was to develop calcium silicate (CaSi)/calcium
S S Salek et al.
Applied microbiology and biotechnology, 97(6), 2743-2752 (2012-11-29)
Silicate minerals can be a source of calcium and alkalinity, enabling CO2 sequestration in the form of carbonates. For this to occur, the mineral needs to be first dissolved in an acidifying process such as the biological process of anaerobic
Emma C Goethals et al.
Langmuir : the ACS journal of surfaces and colloids, 29(2), 658-666 (2012-10-20)
Polymer nanocapsules have gained an important place as drug delivery vehicles for a myriad of biomedical applications. However, the influence of nanocapsule size, wall thickness, and porosity toward controlling the drug delivery efficiency of nanocapsular systems is not well understood.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 742503-1KG | 04061832886459 |
| 742503-500G | 04061832886466 |
| 742503-15KG | 04061833551905 |